Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997

Strahlentherapie und Onkologie

Volumn 177, Issue 7, 2001, Pages 338-344

  Grabenbauer, Gerhard G ^a   Rödel, Claus ^a   Brunner, Thomas ^a   Schulze Mosgau, Stefan ^a   Strnad, Vratislav ^a   Müller, Reinhold G ^a   Iro, Heiner ^a   Sauer, Rolf ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Brachytherapy; Head and neck cancer; Radiotherapy

Indexed keywords

HEMOGLOBIN; IRIDIUM 192;

ADULT; ARTICLE; BONE NECROSIS; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; RADIATION DOSE; TISSUE NECROSIS;

EID: 0034922163     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002416     Document Type: Article

References (32)

1. An original accelerated radiotherapy schedule in stage III and IV head and neck cancers. Results in a multicenter setting
2. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth
3. Carcinoma of the oropharynx: Local failure as the decisive parameter for distant metastases and survival
4. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinoma of the mobile tongue
5. Brachytherapy in the management of the initial stage of the mobile tongue carcinoma
6. Regression models and life tables
7. Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of the base of the tongue: The Creteil experience (1971-1981)
8. Interstitielle und perkutane Strahlentherapie nach begrenzten chirurgischen Eingriffen beim Mundhöhlenkarzinom
9. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: Factors influencing local control and soft tissue complications
10. Nodal CT density and total tumour volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer
11. Treatment of oral cancer by interstitial irradiation using iridium-192
12. Retrospective study of 136 cases of epidermoid carcinoma of the base of the tongue treated at the Alexis Vautrin Centre 1978-1992
13. Non parametric estimation from incomplete observations
14. Conformal treatment planning for interstitial brachytherapy
15. Postoperative brachytherapy alone for T1-2 NO squamous cell carcinomas of the oral tongue and floor of the mouth with close or positive margins
16. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue
17. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: Improved loco-regional disease control compared with surgery alone
18. Indications, techniques and results of postoperative brachytherapy in cancer of the oral cavity
19. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: Reflection of a series of 1344 patients treated at the time of initial presentation
20. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: Comparison of two treatment techniques
21. The efficacy of postoperative radiotherapy for advanced head and neck cancer: Quality of evidence
22. Postoperative radiation therapy for primary vs. recurrent sqamous cell carcinoma of the head and neck: Results of a comparative analysis
23. Influence of boost technique (external beam or brachytherapy) on the outcome of patients with carcinoma of the base of the tongue
24. Early closure of a randomized trial: Surgery and postoperative radiotherapy versus radiotherapy in the management of intraoral tumors
25. In vivo dosimetry in interstitial low-dose rate afterloading therapy with Ir-192 seeds exemplified with head and neck tumors
26. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity
27. Clinical experience with a new remote afterloading system for low dose rate brachytherapy
28. Tumor biologic prognostic parameters in T1N0M0 sqamous cell carcinoma of the oral cavity
29. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: Importance of the proportion of therapy delivered with interstitial therapy
30. Simultaneous radiochemotherapy versus radiotherapy alone in stage III/IV carcinoma of the head and neck
31. Follow-up after histologically verified radical resection of early cancers of the mouth cavity: Results of a prospective multicenter study
32. Radiotherapy of early tongue cancer in patients less than 40 years old